Copy the page URI to the clipboard
Chataway, Joanna and Smith, James
(2006).
DOI: https://doi.org/10.1016/j.worlddev.2005.07.010
Abstract
Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative (IAVI) is one, are being developed to try and bridge the gap between scientific and technological potential and the needs of the poor in developing countries . Consequently, PPPs are now the recipients of large amounts of development donor funds. We look first in this paper at why PPPs have become so popular and at their institutional roots. Second the paper describes key characteristics of IAVI and explains why IAVI represents a new kind of global PPP which is difficult to locate in more traditional approaches to understanding partnerships. Third, we argue that IAVI has had some success in bringing new science and technology closer to the world’s poor and we look in some detail at how it has achieved this success. This success has implications for theoretical and practical approaches to science and technology capacity building.